期刊文献+

人甲状腺鳞癌细胞中端粒酶启动子功能分析 被引量:1

Function of hTERTp in SW579 cells
原文传递
导出
摘要 目的观察不同长度的人端粒酶催化亚单位(hTERT)的启动子对启动增强型绿色荧光蛋白(EGFP)能力的差异,评价启动子启动功能与长度的关系。方法克隆4段不同长度的端粒酶基因起始位点(ATG)上游序列长约2 068、1 135、333和142 bp的启动子片段,通过观察EGFP的荧光强度,确定启动效率。结果显微镜观察荧光亮度及荧光分光光度计检测荧光强度随着启动子长度的缩短而减弱,荧光强度由高至低依次为8.56,7.81,6.88,3.62。结论人端粒酶的表达强度及端粒酶的活性变化与其启动子的长度有关,而肿瘤细胞的端粒酶表达相对增强,可通过下调启动子活性,为肿瘤的靶向性基因治疗提供新思路。 Objective To clone DNA sequence of human telomerase reverse transcriptase promoter(hTERTp) and to explore the function of the promoter in promoting enhanced green flurescence protein(EGFP) and the relationship between promoter length and function.Methods The hTERT promoter of 2068bp,1 135 bp,333bp,142bp were amplified.The hTERT promoters were inserted into upstream of EGFP to reconstruct four recombinant plasmids and transfected into the SW579 cells.Then the fluorescence intensity was detected and the promoter rate was identified.Results The promote effiency of four eukaryotic plasmids decreased with the shortening of the promoter length with the fluoreslenic intensity of 8.56,7.81,6.88 and 3.62 from high to low.Conclusion The human telomerase reverse transcriptase expression and activity change are correlated with the length of the promoter.The research gives a way for tumor gene therapy by down regulation of the acitivity of hTERTp.
出处 《中国公共卫生》 CAS CSCD 北大核心 2011年第2期217-219,共3页 Chinese Journal of Public Health
基金 辽宁省教育厅项目(05L142)
关键词 端粒酶启动子 荧光蛋白 SW579 hTERTp GFP SW579
  • 相关文献

参考文献7

  • 1Horikawa I, Cable PL, Afshari C, et al. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene [J]. Cancer Res,1999,59(4) :826 -830.
  • 2Wooten-Blanks LG, Song P, Senkal CE, et al. Mechanisms of ceramide-mediated repression of the human telomerase revense transcriptase promoter via deacetylation of Sp3 by histone deacetylasel [J]. FASEB ,2007,21:3386 -3397.
  • 3陈伟,陆祥,舒小林,李季蓉.砷对大鼠生精细胞及端粒酶逆转录酶表达影响[J].中国公共卫生,2008,24(11):1382-1384. 被引量:8
  • 4Kyo S,Takakawa M,Taira T,et al. Spl cooperates withc-Myc to activate transcription of the human telomerase reverse transcriptase gene(hTERT) [J]. Nucleic Acids Res,2000,28(3) :669 -677.
  • 5Kyo S, Takakura M, Kanaya T, et al. Estrogen activates telomerase [J]. Cancer Res,1999,59(23) :5917 -5921.
  • 6Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter [ J ]. Hum Mol Genet, 1999,8 ( 1 ) : 137 - 142.
  • 7张明,辛晓燕,李红梅,宋晖.hTERT启动子驱动的TRAIL诱导宫颈癌细胞的凋亡作用[J].细胞与分子免疫学杂志,2007,23(7):638-640. 被引量:5

二级参考文献19

  • 1叶哲伟,陈晓春,熊雅丽,杨军,邢毅飞,侯琳,鲁功成.端粒酶mTERT基因在不同年龄SD鼠睾丸组织内的表达及其意义[J].中华实验外科杂志,2005,22(1):27-28. 被引量:1
  • 2李红梅,宋天保,于月成,曹云新,王红英,宋晖,张明.hTERT基因核心启动子调控的TRAIL基因表达载体的构建及对卵巢癌细胞凋亡的影响[J].细胞与分子免疫学杂志,2006,22(2):243-246. 被引量:5
  • 3Harrison JW, Packman EW, Abbott DD. Acute oral toxicity and chemical and physical properties of arsenic trioxides [ J ]. AMA Arch Ind Health, 1958, 17(2) : 118 - 123.
  • 4Liu L, Franco S, Spyropoulos B, et al. Irregular telomeres impair meiotic synapsis and recombination in mice [ J ]. PNAS, 2004, 101 (17) : 6496 - 6501.
  • 5Tanemura K, Ogura A, Cheong C, et al. Dynamic rearrangement of telomeres during spermatogenesis in mice[ J ]. Dev Biol, 2005, 281 (2) : 196 - 207.
  • 6Feldser DM, Hackett JA, Greider CW. Telomere dysfunction and the initiation of genome instability [ J ]. Nat Rev Cancer, 2003, 3 (8) :623 - 627.
  • 7Liu L, Blasco MA, Trimarchi JR, et al. An essential role for functional telomeres in mouse germ cells during fertilization and early development[J]. Dew Biol, 2002, 249(1) : 74 - 84.
  • 8Schrader M, Muller M, Schulze W, et al. Quantification of telomerase activity, porphobilinogen deaminase and human telomerase reverse transeriptase mRNA in testicular tissue - new parameters for a molecular diagnostic clarification of spermatogenesis disorders[ J ]. Int J Androl, 2002, 25( 1 ) :34 - 44.
  • 9Schrader M, Muller M, Schulze W, et al. Quantification of the ex pression level of the gene encoding the catalytic subunit of telom erase in testicular tissue specimens predicts successful sperm recov ery[J]. Hum Reprod, 2002, 17(1) : 150 - 156.
  • 10Nakayama J,Tahara H,Tahara E,et al.Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas[J].Nat Gene,1998,18(1):65-68.

共引文献10

同被引文献11

  • 1Witt RL. Initial management of thyroid cancer[ J]. Surg Oncol Clin N Am,2008,17(1) :71 -91.
  • 2Choi Y, Park KJ, Ryu S, et al. Papillary thyroid carcinoma invol- ving cervical neck lymph nodes : correlations with lymphangio- genesis and ultrasound features [ J ]. Endocr J, 2012,59 ( 10 ) : 941 - 948.
  • 3Gong J, Pan W, Yang C, et al. Expression of co-stimulators CD28/B7-1 in peripheral blood of patients with breast cancer [ J ]. Breast Cancer Res Treat, 2012,136 ( 2 ) :621 - 622.
  • 4Pan W, Gong J, Yang C, et al. Peripheral blood CD40-CD40Lexpression in human breast cancer [ J ]. Ir J Med Sci, 2013,18 (4) :719 -721.
  • 5Toniato A, Bemardi C, Piotto A, et al. Features of papillary thy- roid carcinoma in patients older than 75 years [J]. Updates Surg,2011,63 (2) : 115 - 118.
  • 6Howell GM, Carty SE, Armstrong MJ, et al. Both BRAF V600E mutation and older age( ≥65 years)are associated with recurrent papillary thyroid cancer [J]. Ann Surg Oncol,2011,18 ( 13 ) : 3566 - 3571.
  • 7陈素秀,费正华,蒋亦燕.温州市居民1997-2008年甲状腺癌患病分析[J].中国公共卫生,2010,26(3):353-354. 被引量:34
  • 8刘泽兵,王丽,叶宣光,张友元.老年前期及老年期甲状腺乳头状癌C-MET和PP60C-SRC蛋白的表达[J].中国老年学杂志,2011,31(1):9-11. 被引量:6
  • 9陈蕾,李维,刘巧艳,张桃桃,刘冰.社区老年人慢性病患病与生活方式调查[J].中国公共卫生,2013,29(5):738-740. 被引量:32
  • 10杨传家,宫建,李景姝,郑刚,李宁,翟德军,刘臻,崔东旭.D2-40在甲状腺乳头状癌淋巴结转移中的作用[J].中国医学工程,2013,21(4):1-2. 被引量:9

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部